{"id":"W2602586354","doi":"10.1021/acsami.6b15987","title":"A New Spin on Antibody–Drug Conjugates: Trastuzumab-Fulvestrant Colloidal Drug Aggregates Target HER2-Positive Cells","year":2017,"lang":"en","type":"article","venue":"ACS Applied Materials & Interfaces","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Canadian Cancer Society Research Institute","keywords":"Trastuzumab; Fulvestrant; Materials science; Drug; Conjugate; Antibody-drug conjugate; Colloid; Nanotechnology; Combinatorial chemistry; Pharmacology; Antibody; Cancer; Monoclonal antibody; Chemical engineering; Medicine; Breast cancer; Tamoxifen; Immunology; Internal medicine; Chemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001714273,0.0002829773,0.0002014812,0.0002547816,0.0002517591,0.0004222981,0.0002204258,0.00044388,0.001077996],"category_scores_gemma":[0.0001863865,0.0001748007,0.0001669919,0.0001243427,0.0002322805,0.0002868306,0.0002612107,0.0004116218,0.0002413425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003410529,"about_ca_system_score_gemma":0.0002605094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009044804,"about_ca_topic_score_gemma":0.001976358,"domain_scores_codex":[0.9998682,0.00001486403,0.000008422257,0.00004572768,0.00004341189,0.00001943626],"domain_scores_gemma":[0.999897,0.00002051873,0.00002053753,0.000009755366,0.00002934249,0.00002293225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000557655,0.00002858872,0.0001663649,0.00004457617,0.00000878802,0.00006387506,0.00003572288,0.00007039437,0.9949557,0.000243894,0.0001231331,0.004203171],"study_design_scores_gemma":[0.00004772131,0.0004033075,0.001169373,0.000005031372,0.00002892311,0.000269413,0.00001253946,0.001128268,0.9917752,0.00004980617,0.005102738,0.000007568934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792189,0.002516413,0.01236914,0.0003057117,0.0001073306,0.0001306596,0.00009217243,0.0002076175,0.005052189],"genre_scores_gemma":[0.9813213,0.0009202645,0.0108478,0.0002520819,0.0000417451,0.00005290034,0.0001418411,0.00005347097,0.006368495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001077996,"threshold_uncertainty_score":0.003606319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0177802712335333,"score_gpt":0.3351322059789082,"score_spread":0.3173519347453749,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}